Atyr Pharma, Stock Alpha and Beta Analysis
| ATYR Stock | 0.75 0.01 1.35% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as aTyr Pharma,. It also helps investors analyze the systematic and unsystematic risks associated with investing in ATyr Pharma, over a specified time horizon. Remember, high ATyr Pharma,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ATyr Pharma,'s market risk premium analysis include:
Beta 0.0847 | Alpha (0.12) | Risk 5.55 | Sharpe Ratio 0.0423 | Expected Return 0.23 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out ATyr Pharma, Backtesting, ATyr Pharma, Valuation, ATyr Pharma, Correlation, ATyr Pharma, Hype Analysis, ATyr Pharma, Volatility, ATyr Pharma, History and analyze ATyr Pharma, Performance. ATyr Pharma, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ATyr Pharma, market risk premium is the additional return an investor will receive from holding ATyr Pharma, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ATyr Pharma,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ATyr Pharma,'s performance over market.| α | -0.12 | β | 0.08 |
ATyr Pharma, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of ATyr Pharma,'s Buy-and-hold return. Our buy-and-hold chart shows how ATyr Pharma, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.ATyr Pharma, Market Price Analysis
Market price analysis indicators help investors to evaluate how ATyr Pharma, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ATyr Pharma, shares will generate the highest return on investment. By understating and applying ATyr Pharma, stock market price indicators, traders can identify ATyr Pharma, position entry and exit signals to maximize returns.
ATyr Pharma, Return and Market Media
The median price of ATyr Pharma, for the period between Thu, Oct 2, 2025 and Wed, Dec 31, 2025 is 0.79 with a coefficient of variation of 13.63. The daily time series for the period is distributed with a sample standard deviation of 0.11, arithmetic mean of 0.82, and mean deviation of 0.09. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | aTyr Pharma, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights ATYR | 11/13/2025 |
2 | aTyr Pharma Inc. Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit | 11/21/2025 |
3 | Shareholders that lost money on aTyr Pharma, Inc. should contact Levi Korsinsky about pending Class Action - ATYR | 12/02/2025 |
4 | ATYR Deadline ATYR Investors with Losses Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit | 12/03/2025 |
5 | INVESTOR DEADLINE APPROACHING Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma | 12/04/2025 |
6 | ATYR 3-DAY DEADLINE ALERT Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure | 12/05/2025 |
7 | ATYR LAWSUIT ALERT The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | 12/08/2025 |
8 | Is aTyr Pharma In A Good Position To Invest In Growth | 12/18/2025 |
About ATyr Pharma, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ATyr or other stocks. Alpha measures the amount that position in aTyr Pharma, has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.28 | 0.18 | 0.17 | Revenue Per Share | 0.006585 | 0.003165 | 0.003006 |
ATyr Pharma, Investors Sentiment
The influence of ATyr Pharma,'s investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ATyr. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ATyr Pharma,'s public news can be used to forecast risks associated with an investment in ATyr. The trend in average sentiment can be used to explain how an investor holding ATyr can time the market purely based on public headlines and social activities around aTyr Pharma,. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ATyr Pharma,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ATyr Pharma,'s and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ATyr Pharma,'s news discussions. The higher the estimated score, the more favorable is the investor's outlook on ATyr Pharma,.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ATyr Pharma, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ATyr Pharma,'s short interest history, or implied volatility extrapolated from ATyr Pharma, options trading.
Build Portfolio with ATyr Pharma,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.